1. Home
  2. CCCC vs BYRN Comparison

CCCC vs BYRN Comparison

Compare CCCC & BYRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • BYRN
  • Stock Information
  • Founded
  • CCCC 2015
  • BYRN 2005
  • Country
  • CCCC United States
  • BYRN United States
  • Employees
  • CCCC N/A
  • BYRN N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • BYRN Industrial Machinery/Components
  • Sector
  • CCCC Health Care
  • BYRN Miscellaneous
  • Exchange
  • CCCC Nasdaq
  • BYRN Nasdaq
  • Market Cap
  • CCCC 396.0M
  • BYRN 326.8M
  • IPO Year
  • CCCC 2020
  • BYRN N/A
  • Fundamental
  • Price
  • CCCC $4.01
  • BYRN $20.31
  • Analyst Decision
  • CCCC Buy
  • BYRN Strong Buy
  • Analyst Count
  • CCCC 6
  • BYRN 3
  • Target Price
  • CCCC $10.00
  • BYRN $17.75
  • AVG Volume (30 Days)
  • CCCC 1.0M
  • BYRN 494.5K
  • Earning Date
  • CCCC 10-31-2024
  • BYRN 10-09-2024
  • Dividend Yield
  • CCCC N/A
  • BYRN N/A
  • EPS Growth
  • CCCC N/A
  • BYRN N/A
  • EPS
  • CCCC N/A
  • BYRN 0.10
  • Revenue
  • CCCC $33,668,000.00
  • BYRN $73,417,000.00
  • Revenue This Year
  • CCCC $76.74
  • BYRN $98.26
  • Revenue Next Year
  • CCCC N/A
  • BYRN $28.91
  • P/E Ratio
  • CCCC N/A
  • BYRN $197.27
  • Revenue Growth
  • CCCC 65.45
  • BYRN 70.65
  • 52 Week Low
  • CCCC $1.06
  • BYRN $5.11
  • 52 Week High
  • CCCC $11.88
  • BYRN $21.62
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 27.45
  • BYRN 63.70
  • Support Level
  • CCCC $3.84
  • BYRN $17.83
  • Resistance Level
  • CCCC $6.20
  • BYRN $21.62
  • Average True Range (ATR)
  • CCCC 0.49
  • BYRN 1.45
  • MACD
  • CCCC -0.19
  • BYRN 0.35
  • Stochastic Oscillator
  • CCCC 6.34
  • BYRN 82.49

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

About BYRN Byrna Technologies Inc.

Byrna Technologies Inc is a designer, manufacturer, retailer and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia and Canada.

Share on Social Networks: